Congo vs United States of America: New or unknown treatment history cases: Pulmonary, bacteriologically

Congo
7,384
in 2023
United States of America
6,535
in 2023
Congo rank
51st
United States of America rank
53rd

New or unknown treatment history cases: Pulmonary, bacteriologically over time

  • Congo
  • United States of America
02.0k4.0k6.0k8.0k201320182023

How they compare

Congo currently reports 7,384 against 6,535 in United States of America, a difference of 849.

That makes Congo's figure about 1.1 times United States of America's.

The two have swapped places 1 time across 11 shared years of data; in 2013 it was United States of America ahead.

Congo ranks 51st and United States of America ranks 53rd of 197 countries.

Across the 2 decades both report, Congo averaged higher in 1 and United States of America in 1.

Head to head by decade

Decade Congo United States of America Difference Ahead
2010s 3,814 5,881 2,067 United States of America
2020s 5,514 5,454 59.5 Congo

Averages of every year both report within each decade.

Frequently asked questions

Which has higher new or unknown treatment history cases: pulmonary, bacteriologically, Congo or United States of America?
Congo, at 7,384 against 6,535 in United States of America as of 2023.
What is the difference in new or unknown treatment history cases: pulmonary, bacteriologically between Congo and United States of America?
849, with Congo ahead.
How many years of comparable data are there for Congo and United States of America?
11 years are reported by both, from 2013 to 2023.
How do Congo and United States of America rank globally for new or unknown treatment history cases: pulmonary, bacteriologically?
Congo ranks 51st and United States of America ranks 53rd of 197 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as New or unknown treatment history cases: Pulmonary, bacteriologically confirmed. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Congo vs United States of America: New or unknown treatment history cases: Pulmonary, bacteriologically. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 03 September 2026, from https://health.statizoid.com/compare/new-or-unknown-treatment-history-cases-pulmonary-bacteriologically-confirmed/congo-rep/united-states/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/new-or-unknown-treatment-history-cases-pulmonary-bacteriologically-confirmed/congo-rep/united-states/">Congo vs United States of America: New or unknown treatment history cases: Pulmonary, bacteriologically</a> — Statizoid

About this data

Indicator
New or unknown treatment history cases: Pulmonary, bacteriologically confirmed
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
210 places, 2,868 data points, 2000–2023
Last refreshed